Articles

  • 1 week ago | insights.citeline.com | Joseph Haas |Lisa Takagi |Sushmita Panda |Xu Hu

    Asia Deal Watch: SunRock, Escugen Collaborate On CCR9-Targeted ADCAxcelead/Lotte Biologics/Kanaph and NextCure/Simcere also unveil ADC-focused pacts, plus deals involving Avata/Oceanus, GSK/Bharat Biotech, Cullinan/Genrix and more.

  • 1 month ago | insights.citeline.com | Joseph Haas |Xu Hu |Anju Ghangurde |Lisa Takagi

    Asia Deal Watch: Lilly Partners With Rznomics On Hearing LossPlus deals involving Minghui/Qilu, LENZ/Lotus, Amicus/Dimerix, Sanofi/Dr. Reddy’s, Henlius/Lotus, Apnimed/Desitin, Formosa/Saval, DAAN/GC Cell, VelaVigo/Ollin and Sol-Gel/Mayne.

  • 1 month ago | insights.citeline.com | Dexter Yan |Xu Hu

    China Biopharma Podcast - 14 May 2025 (Chinese Language)Join our China-based editors Dexter Yan and Xu Hu in this Chinese-language podcast looking at some of their recent interviews and other key coverage. join or China-based editors Dexter Yan and Xu Hu in their latest Chinese language podcast • Source: Citeline/Shutterstock

  • Feb 5, 2025 | insights.citeline.com | Joseph Haas |Dexter Yan |Xu Hu |Vibha Ravi

    Deal Watch: Novo Nordisk, IMMvention To Partner On Sickle Cell DiseasePlus deals involving Vanda/AnaptysBio, OS Therapies/Ayala, Leveragen/Moonlight Bio, Lantheus/Evergreen, Exicure/GPCR, Arrivent/Lepu, InnoCare/KeyMed/Prolium and more.

  • Jan 15, 2025 | insights.citeline.com | Xu Hu

    New China Policies Aim To Improve Market AccessPlus R&D Support And Continue Open-upChina’s State Council has released a wide-ranging set of policy incentives intended to eliminate regulatory barriers and improve market access for innovative drugs. China's State Council on 3 January released a series of encouraging measures for reforms and quality development in the biopharma sector. (Shutterstock)

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →